Demographics (2)
- Age - Subject age (phv00226095.v1.p1)
- Sex - Gender of participant (phv00226096.v1.p1)
Disease Events (6)
- AFFECTION_STATUS - Presence or absence of cancer (phv00226087.v1.p1)
- IS_TUMOR - Tumor status (phv00226102.v1.p1)
- PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00226105.v1.p1)
- TUMOR_GRADE - Tumor grade of sample (phv00226107.v1.p1)
- TUMOR_STAGE - Tumor stage of sample (phv00226106.v1.p1)
- TUMOR_TREATMENT - Type of tumor treatment for sample (phv00226108.v1.p1)
Race and Ethnicity (1)
- Race - Race of participant (phv00226094.v1.p1)
Substance Use (2)
- pack_years - Pack years cigarette smoking (phv00226098.v1.p1)
- smoking_status - Subject smoking history (phv00226097.v1.p1)
Other (17)
- ANALYTE_TYPE - Analyte Type (phv00226101.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00226100.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00226084.v1.p1)
- GENOTYPING_CENTER - Name of the center which conducted genotyping (phv00226109.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00226103.v1.p1)
- PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00226104.v1.p1)
- SAMPLE_ID - De-identified Sample ID (phv00226099.v1.p1)
- SAMPLE_ID - Sample ID (phv00226089.v1.p1)
- SAMPLE_SOURCE - Source repository where samples originate (phv00226090.v1.p1)
- SAMPLE_USE - Sample use. Seq_DNA_SNP_MAF_Sum: Samples were used to generate aggregate mutation annotation file (.maf); Seq_DNA_WholeExome: Whole exome sequencing (phv00226092.v1.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00226110.v1.p1)
- SOURCE_SAMPLE_ID - Sample ID used in the Source Repository (phv00226091.v1.p1)
- SOURCE_SUBJECT_ID - Subject ID used in the Source Repository (phv00226086.v1.p1)
- SUBJECT_ID - De-identified Subject ID (phv00226093.v1.p1)
- SUBJECT_ID - Subject ID (phv00226083.v1.p1)
- SUBJECT_ID - Subject ID (phv00226088.v1.p1)
- SUBJECT_SOURCE - Source repository where subjects originate (phv00226085.v1.p1)